E-mail

E-mail a Wiley Online Library Link

David Cella, Mellar P. Davis, Sylvie Négrier, Robert A. Figlin, M. Dror Michaelson, Andrew G. Bushmakin, Joseph C. Cappelleri, Rickard Sandin, Beata Korytowsky, Claudie Charbonneau, Ewa Matczak and Robert J. Motzer Characterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinoma Cancer 120

Article first published online: 13 MAR 2014 | DOI: 10.1002/cncr.28660

Using phase 3 trial data for sunitinib versus interferon-α in treatment-naive patients with metastatic renal cell carcinoma, retrospective analyses characterized sunitinib-associated fatigue and its impact on patient-reported health-related quality of life. Patients reported worse fatigue during the first sunitinib cycle, but in subsequent consecutive cycles less fatigue was reported with no statistically significant worsening; provider-assessed fatigue did not appear to fully capture patient treatment experience.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

Choose captcha format: Image or Audio. Click here if you need help.

SEARCH